Venous angioma may be associated with epilepsy in children

Bo Ryung Kim1, Yun Jin Lee2, Sang Ook Nam2

  • 1Department of Pediatrics, Pusan National University Hospital, Pusan National University School of Medicine, Busan, Korea.

Korean Journal of Pediatrics
|September 10, 2016
PubMed

Insights

Pediatric venous angiomas (VA), particularly those in the brainstem and cerebellum, are linked to a higher prevalence of epilepsy. This study highlights the association between VA location and seizure risk in children.

Area of Science:

  • Neurology
  • Pediatric Neurology
  • Vascular Malformations

Background:

  • Venous angioma (VA) is the most common congenital intracranial vascular abnormality.
  • Understanding the link between VA and neurological conditions like epilepsy is crucial for diagnosis and management.

Purpose of the Study:

  • To investigate the relationship between venous angiomas and epilepsy in pediatric patients.
  • To identify specific characteristics of children with both VA and epilepsy.

Main Methods:

  • Retrospective review of brain MRI scans from pediatric patients (<18 years).
  • Comparison of epilepsy prevalence between patients with isolated VA and age/sex-matched controls with normal MRI.
  • Analysis of VA location (cerebral hemispheres vs. brainstem/cerebellum) and its correlation with epilepsy.

Main Results:

  • A significantly higher prevalence of epilepsy was observed in the VA group (34.6%) compared to the control group (11.5%).
  • VAs located in the brainstem and cerebellum were associated with a higher epilepsy prevalence (83.3%) than those in the cerebral hemispheres (20.0%).
  • Patients with VA in the brainstem/cerebellum and epilepsy showed more frequent abnormal EEG findings.

Conclusions:

  • Venous angiomas, especially those in the brainstem and cerebellum, are associated with epilepsy in children.
  • The location of VA is a significant factor in the risk of developing epilepsy.
Abstract

Related Concept Videos

Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
1.6K
Seizures: Classification01:13

Seizures: Classification

Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
2.0K
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
1.1K
Antiepileptic Drugs: Glutamate Antagonists01:14

Antiepileptic Drugs: Glutamate Antagonists

Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
1.1K
Vascular Spasm01:16

Vascular Spasm

The vascular phase, also known as vasospasm, is the initial stage of hemostasis, crucial for preventing excessive bleeding when a blood vessel is injured. After a vessel is cut, nerves in the damaged area trigger pain and other sensory impulses. Simultaneously, the smooth muscles in the vessel wall contract, resulting in a vascular spasm. This contraction reduces the vessel's diameter at the injury site, slowing or stopping blood loss through the vessel wall. Vascular spasms typically last...
4.5K
Antiepileptic Drugs: GABAergic Pathway Potentiators01:18

Antiepileptic Drugs: GABAergic Pathway Potentiators

γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
1.6K